Citation: C. Ippoliti, ANTIDIARRHEAL AGENTS FOR THE MANAGEMENT OF TREATMENT-RELATED DIARRHEAIN CANCER-PATIENTS, American journal of health-system pharmacy, 55(15), 1998, pp. 1573-1580
Authors:
KHOURI IF
KEATING M
KORBLING M
PRZEPIORKA D
ANDERLINI P
OBRIEN S
GIRALT S
IPPOLITI C
VONWOLFF B
GAJEWSKI J
DONATO M
CLAXTON D
UENO N
ANDERSSON B
GEE A
CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
Authors:
PRZEPIORKA D
KERNAN N
IPPOLITI C
PAPADOPOULOS E
GIRALT S
KHOURI I
LU J
GAJEWSKI J
DURETT A
CLEARY R
CHAMPLIN R
ANDERSSON B
LIGHT S
Citation: D. Przepiorka et al., PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE, Experimental hematology, 26(8), 1998, pp. 35-35
Authors:
GAJEWSKI J
RONDON G
MIRZA N
MEHRA R
DONATO M
ANDERLINI P
KORBLING M
THERIALT R
KHOURI I
GIRALT S
BUZDAR A
UENO N
PRZEPIORKA D
ANDERSSON B
DURRETT A
SALIBA R
BRUTON J
RAHMAN Z
IPPOLITI C
HORTABAQYI G
RABER M
BAST R
CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
Authors:
PRZEPIORKA D
IPPOLITI C
KHOURI I
ANDERLINI P
FOLLODER J
UENO N
MEHRA R
GIRALT S
GAJEWSKI J
CLEARY K
CLAXTON D
CHAMPLIN R
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 26-26
Authors:
IPPOLITI C
CHAMPLIN R
BUGAZIA N
PRZEPIORKA D
NEUMANN J
GIRALT S
KHOURI I
GAJEWSKI J
Citation: C. Ippoliti et al., USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 15(11), 1997, pp. 3350-3354
Authors:
IPPOLITI C
MORGAN A
WARKENTIN D
VANBESIEN K
MEHRA R
KHOURI I
GIRALT S
GAJEWSKI J
CHAMPLIN R
ANDERSSON B
PRZEPIORKA D
Citation: C. Ippoliti et al., FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR, Bone marrow transplantation, 20(6), 1997, pp. 491-495
Authors:
WOO M
PRZEPIORKA D
IPPOLITI C
WARKENTIN D
KHOURI I
FRITSCHE H
KORBLING M
Citation: M. Woo et al., TOXICITIES OF TACROLIMUS AND CYCLOSPORINE-A AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1095-1098
Authors:
PRZEPIORKA D
ANDERLINI P
IPPOLITI C
KHOURI I
FIETZ T
THALL P
MEHRA R
GIRALT S
GAJEWSKI J
DEISSEROTH AB
CLEARY K
CHAMPLIN R
VANBESIEN K
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS, Bone marrow transplantation, 19(5), 1997, pp. 455-460
Authors:
PRZEPIORKA D
ANDERLINI P
IPPOLITI C
KHOURI I
FOLLODER J
UENO N
MEHRA R
GIRALT S
GAJEWSKI J
CLEARY K
CLAXTON D
ANDERSSON B
KORBLING M
CHAMPLIN R
Citation: D. Przepiorka et al., RISK-FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BLOOD STEM-CELL TRANSPLANT RECIPIENTS, Blood, 90(10), 1997, pp. 441-441
Authors:
KIENAST J
IPPOLITI C
MEHRA R
UENO N
CHAMPLIN R
KHOURI I
GIRALT S
GAJEWSKI J
CLAXTON D
ANDERLINI P
ANDERSSON B
PRZEPIORKA D
Citation: J. Kienast et al., DOSE-INTENSIFIED ANTITHYMOCYTE GLOBULIN (ATG) IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 457-457
Authors:
GIRALT S
MIRZA N
MEHRA R
GAJEWSKI J
ANDERSSON B
PRZEPIORKA D
KHOURI I
KORBLING M
COHEN A
RAHMAN Z
VANBESIEN K
IPPOLITI C
BRUTON J
ANDERLINI P
UENO N
CHAMPLIN R
Citation: S. Giralt et al., RESULTS OF CD8 DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (CD8- ALLO-PBSC) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 1657-1657
Authors:
GIRALT S
COHEN A
MEHRA R
GAJEWSKI J
ANDERSSON B
PRZEPIORKA D
KHOURI I
KORBLING M
DAVIS M
VANBESIEN K
IPPOLITI C
BRUTON J
ANDERLINI P
UENO N
CHAMPLIN R
Citation: S. Giralt et al., PRELIMINARY-RESULTS OF FLUDARABINE MELPHALAN OR 2CDA/MELPHALAN (2CDA/M) AS PREPARATIVE REGIMENS FOR ALLOGENEIC PROGENITOR-CELL TRANSPLANTATION (ALLO-PCT) IN POOR CANDIDATES FOR CONVENTIONAL MYELOABLATIVE CONDITIONING/, Blood, 90(10), 1997, pp. 1853-1853
Authors:
KHOURI IF
IPPOLITI C
GAJEWSKI J
PRZEPIORKA D
CHAMPLIN RE
Citation: If. Khouri et al., NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, American journal of hematology, 52(4), 1996, pp. 313-315
Authors:
MCCARTHY PL
WILLIAMS L
HARRISBACILE M
YEN J
PRZEPIORKA D
IPPOLITI C
CHAMPLIN R
FAY J
BLOSCH C
JACOBS C
ANASETTI C
Citation: Pl. Mccarthy et al., A CLINICAL-PHASE I II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN GLUCOCORTICOID-RESISTANT GRAFT-VERSUS-HOST DISEASE/, Transplantation, 62(5), 1996, pp. 626-631
Authors:
PRZEPIORKA D
IPPOLITI C
KHOURI I
ANDERLINI P
MEHRA R
GIRALT S
GAJEWSKI J
FRITSCHE H
DEISSEROTH AB
CLEARY K
CHAMPLIN R
VANBESIEN K
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC TRANSPLANTATION FOR ADVANCED LEUKEMIA - IMPROVED SHORT-TERM OUTCOME WITH BLOOD STEM-CELL GRAFTS AND TACROLIMUS, Transplantation, 62(12), 1996, pp. 1806-1810
Authors:
PRZEPIORKA D
IPPOLITI C
KHOURI I
WOO M
MEHRA R
LEBHERZ D
GIRALT S
GAJEWSKI J
FISCHER H
FRITSCHE H
DEISSEROTH AB
CLEAN K
CHAMPLIN R
VANBESIEN K
ANDERSSON B
MAHER R
FITZSIMMONS W
Citation: D. Przepiorka et al., TACROLIMUS AND MINIDOSE METHOTREXATE FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MATCHED UNRELATED DONOR MARROW TRANSPLANTATION, Blood, 88(11), 1996, pp. 4383-4389
Authors:
ABBOTT B
IPPOLITI C
NEUMANN J
BRUTON J
CHAMPLIN R
Citation: B. Abbott et al., STANDARD PRACTICE PROTOCOL OF GRANISETRON (KYTRIL(R)) FOR ANTIEMETIC CONTROL IN BONE-MARROW TRANSPLANT (BMT) PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION (TBI), Blood, 88(10), 1996, pp. 3737-3737
Authors:
PRZEPIORKA D
IPPOLITI C
KHOURI I
ANDERLINI P
LEBHERZ D
VANBESIEN K
UENO N
MEHRA R
GIRALT S
GAJEWSKI J
FRITSCHE H
CLEARY K
CLAXTON D
CHAMPLIN R
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., MICRODOSE METHOTREXATE VS METHYLPREDNISOLONE IN COMBINATION WITH TACROLIMUS FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 1659-1659
Authors:
PRZEPIORKA D
NATH R
IPPOLITI C
MEHRA R
HAGEMEISTER F
DIENER K
DIMOPOULOS M
GIRALT S
KHOURI I
SAMUELS B
VANBESIEN K
ANDERSSON B
DEISSEROTH AB
LUNA M
CABANILLAS F
CHAMPLIN R
Citation: D. Przepiorka et al., A PHASE I-II STUDY OF HIGH-DOSE THIOTEPA, BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS TRANSPLANTATION FOR MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 17(5-6), 1995, pp. 427-433
Authors:
PRZEPIORKA D
CHAN KW
CHAMPLIN RE
CULBERT SJ
PETROPOULOS D
IPPOLITI C
KHOURI I
HUH YO
VREISENDORP H
DEISSEROTH AB
BLEYER WA
Citation: D. Przepiorka et al., PREVENTION OF GRAFT-VERSUS-HOST-DISEASE WITH ANTI-CD5 RICIN-A CHAIN IMMUNOTOXIN AFTER CD3-DEPLETED HLA-NONIDENTICAL MARROW TRANSPLANTATION IN PEDIATRIC LEUKEMIA PATIENTS, Bone marrow transplantation, 16(6), 1995, pp. 737-741
Authors:
IPPOLITI C
PRZEPIORKA D
MEHRA R
NEUMANN J
WOOD J
CLAXTON D
GAJEWSKI J
KHOURI I
VANBESIEN K
ANDERSSON B
DEISSEROTH AB
DINNEY CP
Citation: C. Ippoliti et al., INTRAVESICULAR CARBOPROST FOR THE TREATMENT OF HEMORRHAGIC CYSTITIS AFTER MARROW TRANSPLANTATION, Urology, 46(6), 1995, pp. 811-815
Authors:
PRZEPIORKA D
IPPOLITI C
KHOURI I
ANDERLINI P
STEIN L
VANBESIEN K
MEHRA R
GIRALT S
GAJEWSKI J
FRITSCHE H
DEISSEROTH AB
CLEARY K
CHAMPLIN R
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., TACROLIMUS VS CYCLOSPORINE FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Blood, 86(10), 1995, pp. 1568-1568